{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:19:02Z","timestamp":1791433142626,"version":"4.3.3"},"reference-count":103,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T00:00:00Z","timestamp":1233187200000},"content-version":"vor","delay-in-days":394,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:p>\n                    Cannabinoids suppress behavioural responses to noxious stimulation and suppress nociceptive transmission through activation of CB\n                    <jats:sub>1<\/jats:sub>\n                    and CB\n                    <jats:sub>2<\/jats:sub>\n                    receptor subtypes. CB\n                    <jats:sub>1<\/jats:sub>\n                    receptors are expressed at high levels in the central nervous system (CNS), whereas CB\n                    <jats:sub>2<\/jats:sub>\n                    receptors are found predominantly, but not exclusively, outside the CNS. CB\n                    <jats:sub>2<\/jats:sub>\n                    receptors are also upregulated in the CNS and dorsal root ganglia by pathological pain states. Here, we review behavioural, neurochemical and electrophysiological data, which identify cannabinoid CB\n                    <jats:sub>2<\/jats:sub>\n                    receptors as a therapeutic target for treating pathological pain states with limited centrally, mediated side effects. The development of CB\n                    <jats:sub>2<\/jats:sub>\n                    \u2010selective agonists (with minimal affinity for CB\n                    <jats:sub>1<\/jats:sub>\n                    ) as well as mutant mice lacking CB\n                    <jats:sub>2<\/jats:sub>\n                    receptors has provided pharmacological and genetic tools required to evaluate the effectiveness of CB\n                    <jats:sub>2<\/jats:sub>\n                    agonists in suppressing persistent pain states. This review will examine the efficacy of cannabinoid CB\n                    <jats:sub>2<\/jats:sub>\n                    \u2010selective agonists in suppressing acute, inflammatory and neuropathic nociception following systemic and local routes of administration. Data derived from behavioural, neurochemical and neurophysiological approaches are discussed to better understand the relationship between antinociceptive effects induced by CB\n                    <jats:sub>2<\/jats:sub>\n                    \u2010selective agonists in behavioural studies and neural mechanisms of pain suppression. Finally, the therapeutic potential and possible limitations of CB\n                    <jats:sub>2<\/jats:sub>\n                    \u2010based pharmacotherapies for pathological pain states induced by tissue and nerve injury are discussed.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>British Journal of Pharmacology<\/jats:italic>\n                    (2008)\n                    <jats:bold>153<\/jats:bold>\n                    , 319\u2013334; doi:\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"doi\" xlink:href=\"10.1038\/sj.bjp.0707531\">10.1038\/sj.bjp.0707531<\/jats:ext-link>\n                    ; published online 12 November 2007\n                  <\/jats:p>","DOI":"10.1038\/sj.bjp.0707531","type":"journal-article","created":{"date-parts":[[2007,11,12]],"date-time":"2007-11-12T06:07:56Z","timestamp":1194847676000},"page":"319-334","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":382,"title":["Cannabinoid CB\n                    <sub>2<\/sub>\n                    receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain"],"prefix":"10.1111","volume":"153","author":[{"given":"J","family":"Guindon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A G","family":"Hohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1991.66.1.212"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.04684.x"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707303"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1996.0704p.x"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704110"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00211-9"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/28393"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)00988-8"},{"key":"e_1_2_9_10_1","first-page":"CR185","article-title":"Type 1 diabetes mellitus in Catalonia: chronic complications and metabolic control ten years after onset","volume":"10","author":"Cant\u00f3n A","year":"2004","journal-title":"Med Sci Monit"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2006.12.004"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00454-7"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0140525X97251484"},{"key":"e_1_2_9_14_1","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1523\/JNEUROSCI.12-09-03665.1992","article-title":"The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin\u2010induced tissue injury","volume":"12","author":"Coderre TJ","year":"1992","journal-title":"J Neurosci"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00490-5"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1472-8206.2002.00094.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1470919"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.57.011205.135648"},{"key":"e_1_2_9_19_1","first-page":"359","volume-title":"Textbook of Pain","author":"Dubner R","year":"1999"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.03.037"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2004.03690.x"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.09.005"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.8.3376"},{"key":"e_1_2_9_24_1","first-page":"443","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder CC","year":"1995","journal-title":"Mol Pharmacol"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00474-7"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0960-894X(96)00426-X"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1995.tb20780.x"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja00730a036"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(97)00690-5"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm061195"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(96)03104-1"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01336-8"},{"key":"e_1_2_9_33_1","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0022-3565(24)35367-4","article-title":"Cloning and pharmacological characterization of the rat CB2 cannabinoid receptor","volume":"292","author":"Griffin G","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.12.002"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.12.007"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706990"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.08.045"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767150-00002"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706984"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.25.14228"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(88)90026-7"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(96)13308-5"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-3084(02)00154-8"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.060079"},{"issue":"1","key":"e_1_2_9_45_1","first-page":"S121","article-title":"Selective activation of cannabinoid CB2 receptors suppresses chemotherapeutic neuropathy evoked by paclitaxel and vincristine administration","volume":"11","author":"Hohmann AG","year":"2007","journal-title":"Eur J Pain"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)01148-X"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2004.07.030"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612003399347"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(99)00219-9"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1834309100"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409888102"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.12.018"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.05.059"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90041-9"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.10.020"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1992.sp019068"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm980363y"},{"key":"e_1_2_9_58_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator\u2010activated receptor\u2010alpha mediates the anti\u2010inflammatory actions of palmitoylethanolamide","volume":"67","author":"LoVerme J","year":"2005","journal-title":"Mol Pharmacol"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.111385"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00321-9"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2005.03380.x"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)00195-C"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00015-5"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)00109-D"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/365061a0"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(03)00126-X"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(02)00870-9"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00886.2003"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-3084(02)00143-3"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(00)00031-9"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)00175-6"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4637.2001.002001008.x"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707003"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00121-2"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200310000-00031"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707333"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/ilar.40.3.111"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)00174-5"},{"key":"e_1_2_9_79_1","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0022-3565(24)37266-0","article-title":"SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor","volume":"284","author":"Rinaldi\u2010Carmona M","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000264765.33673.6c"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702351"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(00)00135-0"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2005.04206.x"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.01.020"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(90)91074-S"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00565.2003"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.11.008"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000204318.35194.ed"},{"key":"e_1_2_9_89_1","first-page":"352","article-title":"Activation of the human peripheral cannabinoid receptor results in inhibtion of adenylyl cyclase","volume":"48","author":"Slipetz DM","year":"1995","journal-title":"Mol Pharmacol"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90003-T"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1992.sp019069"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2004.12.008"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1115740"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2005.02.010"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20821"},{"key":"e_1_2_9_96_1","first-page":"509","volume-title":"Cannabinoids\u2010 Handbook of Experimental Pharmacology","author":"Walker JM","year":"2005"},{"key":"e_1_2_9_97_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.042010"},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003"},{"key":"e_1_2_9_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(02)00445-1"},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.10.043"},{"key":"e_1_2_9_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2005.06.009"},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706838"},{"key":"e_1_2_9_103_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2003.02704.x"},{"key":"e_1_2_9_104_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.10.5780"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Fsj.bjp.0707531","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Fsj.bjp.0707531","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1038\/sj.bjp.0707531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T01:53:16Z","timestamp":1737510796000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1038\/sj.bjp.0707531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1038\/sj.bjp.0707531"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjp.0707531","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"2009-01-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}